in silico analysis to metabolomics
DESCRIPTION
MetabolomicsTRANSCRIPT
![Page 1: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/1.jpg)
Toral Joshi
M.Phil (Bioinformatics)
Disha Life Sciences
IN SILICO ANALYSIS TO METABOLOMICS
![Page 2: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/2.jpg)
INTRODUCTION
Metabolism:- It is the set of chemical reactions that happen in living organisms to maintain life.
Catabolism :- Breaks down organic matter.
Anabolism :- Uses energy to construct components of cells such as proteins and mucliec acid
Metabolite :- Metabolites are the intermediates and products of metabolism.Usually metabolites refers to small molecules.
Metabolic Pathway :- Series of Chemical reaction occuring within the cell.
Metabolic Network :- Collection of Metabolic pathways is called a metabolic Network.
![Page 3: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/3.jpg)
INTRODUCTION
• Metabolome :- Metabolome refers to the complete set of small-molecule metabolites
• Metabolomics:-Investigation of metabolic regulation and fluxes in individual cells or cell types.Metabolomics is the "systematic study of the unique chemical fingerprints that specific cellular processes leave behind" - specifically, the study of their small-molecule metabolite profiles.
• Metabonomics:- the determination of systemic biochemical profiles and regulation of function in whole organisms by analysing biofluidsand tissues
![Page 4: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/4.jpg)
The History of Metabolomics
Linus Pauling hypothesised on the predictive capacity of chromatographic profiling of bodily fluids for detection and diagnosis of human disease.
Chromatographic separation techniques were developed in the late 1960's.
Robinson and Pauling published “Quantitative Analysis of Urine Vapor and Breath by Gas-Liquid Partition Chromatography” in 1971.
The Metabolome and Metabolomics were coined in the 1990s.
In January 2007 the Human Metabolome Project, completed the first draft of thehuman metabolome, consisting of 2,500 metabolites, 1,200 drugs and 3,500 foodcomponents.
![Page 5: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/5.jpg)
WHAT IS A METABOLITE?
• Any organic molecule detectable in the body with a MW < 1000 Da
• Includes peptides, oligonucleotides, sugars, nucelosides, organic acids, ketones, aldehydes, amines, amino acids, lipids, steroids, alkaloids and drugs (xenobiotics)
• Includes human & microbial products
• Concentration > 1mM
![Page 6: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/6.jpg)
SIZE OF METABOLOMES VARIES GREATLY
• Saccharomyces cereviciae ~ 600 metabolites (compared to over ~6,000 genes)
• Plants: ~ 200,000 primary & secondary metabolites• Human metabolome: Much larger
• Degree of diversity encompasses:• Molecular weights (wide range of mwt)• Polar (carbohydrates)• Non-polar (terpenoids & lipids)• Volatile vs. non-volatile organic compounds
![Page 7: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/7.jpg)
METABOLITES
Some common metabolites include:• cholesterol• glucose, sucrose, fructose• amino acids• lactic acid, uric acid• ATP, ADP• drug metabolites, legal and illegal
These are produced in metabolic pathways, such as the Krebs (citrate) cycle for oxidation of glucose.
![Page 8: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/8.jpg)
METABOLITES & FUNCTION
• Serum Creatinine
• Late stage organ stress and tissue breakdown
• TMAO
• Early stage buffering response
• Creatine, methyl-histidine, taurine, glycine
• Tissue damage, muscle breakdown, remodelling
• Citrate, lactate, acetate, acetone
• Oxidative stress, apoptosis, anoxia, ischemia
• Histamine, chlorotyrosine, thromoxane, NO3
• Immune response, inflammation
![Page 9: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/9.jpg)
THE PYRAMID OF LIFE
25,000 Genes
2500 Enzymes
1400Chemicals
Metabolomics
Proteomics
Genomics
![Page 10: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/10.jpg)
Primary Molecules
Secondary Molecules
Metabolomics
Chemical Fingerprint
![Page 11: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/11.jpg)
METABONOMICS
• Evaluation of tissues & biological fluids for changes in endogeneous metabolite levels resulting from disease, genetic changes or (particularly important for pharmaceuticals) from therapeutic treatments.
![Page 12: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/12.jpg)
METABOLITE PROFILING
Both Metabolomics and Metabonomics involve nonselective or non bias analysis.
In contrast ‘Metabolite profiling’ involves the identification and quantitation by a particular analytical procedure of a predefined set of metabolites of known or unknown identity and belonging to a selected metabolic pathway.
![Page 13: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/13.jpg)
Metabolome analysis
Metabolite target analysis
Specific metabolites
e.g. particularenzyme system that
would be directlyaffected by abiotic
or bioticperturbation.
Metaboliteprofiling
Group of metabolites,
e.g. a class ofcompounds such
ascarbohydrates,
aminoacids or those
associated with aspecific pathway.
Metabolomics
All metabolites, present
in a cell or sample.Comprehensiveanalysis of the
wholemetabolome under
agiven set ofconditions.
Metabolitefingerprinting
The intention is notto identify each
observedcompound but tocompare patterns
orfingerprints of
metabolites thatchange in responseto disease or toxin
exposure.
![Page 14: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/14.jpg)
IMPORTANT TERMINOLGIES
• Some important terminology that may be confusing:• Target metabolite analysis: Focussed approach, few metabolites• Metabolite profiling: Metabolic networks and compound classes• Metabolomics: Analysis of “all” metabolites in a specific living
organism• Metabonomics = Metabolomics in clinical disease• Metabolic fingerprinting: Rapid classification of metabolite groups• Metabolic pathway – metabolic network• Pleiotropic effects – rather a rule than an exception
![Page 15: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/15.jpg)
METABOLOMICS
Integration of genomics, transcriptomics, proteomics and metabolomics is a goal of systems biology.
![Page 16: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/16.jpg)
![Page 17: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/17.jpg)
THE ”OMICS”
• Term Investigates RoleGenomics DNA sequences Information
Transcriptomics mRNA sequences Messenger
Proteomics Protein sequences Factory
Metabolomics Metabolites Function
Phenomics Phenotype Form
![Page 18: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/18.jpg)
HUMAN METABOLOME PROJECT
• $7.5 million Genome Canada Project launched in Jan. 2005
• Mandate to quantify (normal and abnormal ranges) and identify all metabolites in urine, CSF, plasma and WBC’s
• Make all data freely and electronically accessible (HMDB)
• Make all cmpds publicly available (HML)
![Page 19: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/19.jpg)
HUMAN METABOLOME PROJECT
• Purpose is to facilitate Metabolomics
• Objective is to improve
• Disease identification
• Disease prognosis & prediction
• Disease monitoring
• Drug metabolism and toxicology
• Linkage between metabolome & genome
• Development of software for metabolomics
![Page 20: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/20.jpg)
20
BIOCHEMICAL PROFILE MAP TO METABOLIC PATHWAYS
Biochemical Profile
![Page 21: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/21.jpg)
![Page 22: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/22.jpg)
Metabolomics
Separation Methods
GC
HPLC
Capillary Electrophoresis
Detection Methods
MS
NMR
ANALYTICAL TECHNOLOGIES
![Page 23: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/23.jpg)
ANALYTICAL TECHNOLOGIES: SEPARATION
Gas chromatographyIt offers high resolution, but requires chemical derivatization for many biomolecules and only volatile chemicals can be analysed without derivatization.Gas-liquid chromatography - involves a sample being vapourised and injected onto the head of the chromatographic column. The sample is transported through the column by the flow of inert, gaseous mobile phase. The column itself contains a liquid stationary phase which is adsorbed onto the surface of an inert solid.
![Page 24: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/24.jpg)
High performance liquid chromatography
ANALYTICAL TECHNOLOGIES: SEPARATION
HPLC has lower resolution than GC, but it does have the advantage that a much wider range of analytes can potentially be measured.
![Page 25: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/25.jpg)
Capillary electrophoresis
ANALYTICAL TECHNOLOGIES: SEPARATION
It has a higher theoretical separation efficiency than HPLC and is suitable for usewith a wider range of metabolite classes than is GC. As for all electrophoretictechniques, it is most appropriate for charged analytes.
![Page 26: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/26.jpg)
ANALYTICAL TECHNOLOGIES: DETECTION
Mass spectrometryUsed to identify and to quantify metabolites after separation by GC, HPLC, or CE. In addition, mass spectral fingerprint libraries exist that allow identification of a metabolite according to its fragmentation pattern.
There are many types of mass spectrometers that not only analyze the ions differently but produce different types of ions; however they all use electric and magnetic fields to change the path of ions in some way.
Sector instrument
![Page 27: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/27.jpg)
Nuclear magnetic resonance (NMR) spectroscopy
ANALYTICAL TECHNOLOGIES: DETECTION
NMR is almost the only detection technique whichdoes not rely on extraction and separation of theanalytes, and the sample can thus be analysed in vivoand recovered for further analyses.
Any molecule containing one or more atoms with anon-zero magnetic moment can potentially bedetected. In practice metabolites are labelled byfeeding substrates containing 1H, 13C, 14N, 15N or 31Pisotopes.
NMR is close to being a universal detector. However,it possesses one major disadvantage, which is that it isrelatively insensitive compared to mass spectrometry-based techniques.
![Page 28: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/28.jpg)
POST-GENOMIC ERA OF BIOLOGY
Genome
Gene expression (mRNA)
Proteins
Metabolism
![Page 29: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/29.jpg)
Genome
Gene expression (mRNA)
Proteins
Metabolism
Metabolomics
Proteomics
Genomics
Transcriptomics (Microarrays)
POST-GENOMIC ERA OF BIOLOGY
![Page 30: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/30.jpg)
FunctionalMolecular
Phenotype
Genome
Gene expression (mRNA)
Proteins
Metabolism
Proteomics
Genomics
Transcriptomics (Microarrays)
Metabolomics
Genotype
POST-GENOMIC ERA OF BIOLOGY
![Page 31: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/31.jpg)
FunctionalMolecular
Phenotype
Genome
Gene expression (mRNA)
Proteins
Metabolism
Metabolomics
Proteomics
Genomics
Environmental stressors
Transcriptomics (Microarrays)
Genotype
POST-GENOMIC ERA OF BIOLOGY
![Page 32: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/32.jpg)
"METABOLOMICS: HOW AND WHAT FOR ? "
6 steps:
1- sampling (storage)
2- metabolite extraction (standardisation, reproducibility)
3- biochemical analysis (GC-MS, LC-MS, NMR)
4- data pre-processing (base line correction….)
5- data visualisation and mining (PCA, data bases)
6- integration of data (metabolic pathways, genome..)
![Page 33: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/33.jpg)
Identify metabolites and pathways that influence drug response
![Page 34: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/34.jpg)
Nature Reviews Genetics 5; 669-676 (2004);
![Page 35: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/35.jpg)
To monitor in parallel hundreds or even thousands of metabolites, high-
throughput techniques are required that enable screening for relative changes
rather than absolute concentrations of compounds
![Page 36: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/36.jpg)
• Samples (complex tissues, cells, etc.)
• Extract metabolites from sample.
• Separate metabolites (chromatography).
• Detect and characterize individual metabolites
• Quantify and perform data analysis.
METABOLOME ANALYSIS
![Page 37: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/37.jpg)
Data is collected from instruments (GCMS,LCMS,NMR,CEMS,FTMS,etc.) in high a throughput manner.
Data is deconvoluted and stored automatically in appropriate format and database
Computer based applications automatically transform analysedata .
Statistically significant differences and/or similarities are reported to researcher in an easy to understand format.
METABOLOME DATA ANALYSIS
![Page 38: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/38.jpg)
Protein
MetaboliteTranscript
Gene
![Page 39: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/39.jpg)
APPLICATIONS
![Page 40: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/40.jpg)
• Genetic Disease Tests
• Nutritional Analysis
• Clinical Blood Analysis
• Clinical Urinalysis
• Cholesterol Testing
• Drug Compliance
• Dialysis Monitoring
• MRS and fMRI
• Toxicology Testing
• Clinical Trial Testing
• Fermentation Monitoring
• Food & Beverage Tests
• Nutraceutical Analysis
• Drug Phenotyping
• Water Quality Testing
• Organ Transplantation
METABOLIC PROFILING: THE POSSIBILITIES
![Page 41: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/41.jpg)
MEDICAL METABOLOMICS• Generate metabolic “signatures” for disease states or host
responses
• Obtain a more “holistic” view of metabolism (and treatment)
• Accelerate assessment & diagnosis
• More rapidly and accurately (and cheaply) assess/identify disease phenotypes
• Monitor gene/environment interactions
• Rapidly track effects from drugs/surgery
![Page 42: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/42.jpg)
APPLICATIONS IN METABOLITE IMAGING
N-acetyl-aspartateLactate
Glutamate
CitrateAlanine
![Page 43: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/43.jpg)
METABOLIC MICROARRAYS
Ace
tic A
cid
Bet
aine
Car
nitin
eC
itric
Aci
dC
reat
inin
eD
imet
hylg
lyci
neD
imet
hyla
min
eH
ippu
lric A
cid
Lact
ic A
cid
Succ
inic
Aci
dTr
imet
hyla
min
eTr
imn-
N-O
xide
Ure
aLa
ctos
eSu
beric
Aci
dSe
baci
c Aci
dH
omov
anill
ic A
cid
Thre
onin
eA
lani
neG
lyci
neG
luco
se
Patient 1Patient 2Patient 3Patient 4Patient 5Patient 6Patient 7Patient 8Patient 9Patient 10Patient 11Patient 12Patient 13Patient 14Patient 15
NormalBelow NormalAbove NorrmalAbsent
![Page 44: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/44.jpg)
DNANutrigenetics
Nutritional Epigenetics
Nutritional Transcriptomics
Proteomics
Metabolomics
Bioactive Food Component
RNA
Protein
Metabolite
The “Omics” of Nutrition
Phenotype
Nutrigenomics
![Page 45: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/45.jpg)
DNANutrigenetics
Nutritional Epigenetics
Nutritional Transcriptomics
Proteomics
Metabolomics
Bioactive Food Component
RNA
Protein
Metabolite
Nutritional Metabolomics
Phenotype
Nutrigenomics
![Page 46: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/46.jpg)
Intake of Dietary
Constituent
AbsorbedDose Biologically
Effective Dose
Inactive Metabolite
Altered Altered Structure Structure/ FunctionFunction
Health Effects+ and -
Susceptibility (Genetic/
Environment)
Early BiologicEffect
Can Metabolomics Shed Light on these 3 Nutrition Related Biomarkers
![Page 47: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/47.jpg)
CAN METABOLOMICS PROVIDE CLUES ABOUT THE PROGRESSION OF DISEASE
TreatmentOptions
QualityOf Life
GeneticRisk
EarlyDetection
Patient Stratification
DiseaseStaging
Outcomes
Natural History of Disease Treatment History
Biomarkers
Environment+ Lifestyle
![Page 48: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/48.jpg)
METABOLOMICS: APPLICATIONS
• Identification of metabolic biomarkers that change as an indicator of the presence of disease or in response to drug-based intervention.
• Determination of the effect of biochemical or environmental stresses on plants or microbes
![Page 49: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/49.jpg)
APPLICATIONS (CONT’D)
• Bacterial characterizations
• Human health assessments (potential for “translational research”?)
• Metabolic engineering
![Page 50: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/50.jpg)
Metabolomics Applications
Diagnosis
Disease (e.g. coronary heart disease).Toxicology
Functional genomics
Ascribing functions to genes
Systems biology
Integration with data sets from other omics.
![Page 51: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/51.jpg)
• Genetic Disease Tests
• Nutritional Analysis
• Clinical Blood Analysis
• Clinical Urinalysis
• Cholesterol Testing
• Drug Compliance
• Transplant Monitoring
• MRS and fMRI
• Food & Beverage Tests
• Nutraceutical Analysis
• Drug Phenotyping
• Water Quality Testing
• Petrochemical Analysis • Fermentation Monitorin• Toxicology Testing
• Clinical Trial Testing
OTHER APPLICATIONS
![Page 52: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/52.jpg)
Metabolomics approaches have been widely used to provide a phenotypic description of a cell as a function
of time and/or condition by a set of metabolites.
Changes in levels of metabolic intermediates of a sequential series of reactions are often more
pronounced than the changes in enzymatic kinetics or individual fluxes. For this reason, metabolomics is
considered a sensitive tool for the study of genotype-phenotype correlations as well as the pharmacological
and toxicological effects of drugs.
![Page 53: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/53.jpg)
DATABASES FOR METABOLOMICS
![Page 54: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/54.jpg)
KEGG• KEGG is a suite of databases.
• PATHWAY
• holds the current knowledge on molecular interaction networks,
• including metabolic pathways, regulatory pathways,and molecular complexes.
• GENES
• is a collection of gene catalogs for all the complete genomes and some
• partial genomes. Each gene catalog is computationally derived from public
• resources, and is manually reannotated for reconstruction of KEGG pathways.
• KEGG GENES is associated with KEGG GENOME containing chromosome maps,
• KO for manually curated ortholog groups, and KEGG SSDB for computationally
• generated ortholog/paralog clusters and gene clusters.
• COMPOUND/
• GLYCAN/REACTION contains information about chemical
• compounds and reactions.
![Page 55: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/55.jpg)
KEGG:- LIGAND DATABASE• LIGAND Database of Chemical Compounds and Reactions in
Biological Pathways
• provide the linkage between chemical and biological aspects of life in the
• light of enzymatic reactions.
• The database consists of four sections:
• COMPOUND, GLYCAN, REACTION, and ENZYME.
![Page 56: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/56.jpg)
![Page 57: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/57.jpg)
![Page 58: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/58.jpg)
![Page 59: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/59.jpg)
![Page 60: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/60.jpg)
FOOD COMPONENT DATABASE
![Page 61: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/61.jpg)
![Page 62: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/62.jpg)
![Page 63: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/63.jpg)
![Page 64: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/64.jpg)
![Page 65: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/65.jpg)
![Page 66: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/66.jpg)
![Page 67: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/67.jpg)
![Page 68: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/68.jpg)
![Page 69: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/69.jpg)
![Page 70: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/70.jpg)
![Page 71: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/71.jpg)
SOFTWARES FOR METABOLOMICS
![Page 72: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/72.jpg)
![Page 73: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/73.jpg)
![Page 74: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/74.jpg)
![Page 75: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/75.jpg)
![Page 76: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/76.jpg)
![Page 77: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/77.jpg)
![Page 78: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/78.jpg)
![Page 79: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/79.jpg)
![Page 80: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/80.jpg)
![Page 81: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/81.jpg)
![Page 82: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/82.jpg)
![Page 83: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/83.jpg)
![Page 84: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/84.jpg)
![Page 85: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/85.jpg)
![Page 86: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/86.jpg)
![Page 87: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/87.jpg)
LIST OF OTHER SOFTWARES
• mzmine and mzmine2 (http://mzmine.sourceforge.net/) - mzxml, mzdata, netCDF and XCalibur data (LC-MS, GC-MS, MS data)
• metAlign (RIKILT-WUR Institute of Food Safety) - LC-MS and GC-MS data
• BinBase (fiehnlab.ucdavis.edu) • xcms and xcms2 (Scripps) - netCDF data (LC-MS, GC-MS, MS and
MS2 data)• MarkerLynx (Waters) (LC-MS data)• BluFuse (BlueGnome) - for MS and NMR data • SpecAlign University of Oxford (Jason Wong) - Alignment of SELDI,
MALDI, NMR, RAMAN, IR (via TXT import)• HiRes (Columbia University Medical Center) - for NMR data• msInspect (Proteomics Fred Hutchinson Cancer Center)• Progenesis PG600 (Nonlinear) - for MALDI and SELDI mass spectra• caMassClass (NCBI) - for SELDI protein mass spectra
![Page 88: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/88.jpg)
SOFTWARESXalign - for LC-MS data [DOI] - request here
msalign from Matlab Bioinformatics Toolbox - for MS data (example using msalign)
pairseqsim - (Bioconductor - Witold Wolski) - for mass spectra [DOI]
Randolph Yasui code - [DOI] download Matlab code and WMTSA wavelet toolbox
RTAlign algorithm of MSFACTs (noble.org) - GC-MS and LC-MS data
Genedata Expressionist (genedata.com) - for LC-MS and infusion MS data.
MS Align (David Grant - Uconn.edu) - for high resolution mass spectral data [DOI]
LCMSWARP (PNNL) - for proteomics and metabolomics LC-MS data (http://ncrr.pnl.gov/software)
ChromAlign (Thermo) - included in Sieve and Biosieve package for LC-MS and LC-MS-MS data
PETAL - Peptide Element Alignment for LC-MS data (http://peiwang.fhcrc.org/research-project.html)
MarkerView (ABI/Sciex) - for LC-MS and MALDI data peak picking and alignment and statistics
![Page 89: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/89.jpg)
SOFTWARES• MathDAMP (Keio University) - for GC-MS, LC-MS, CE-MS data with Mathematica source code [DOI]
• NameLess - for MALDI MS and FT-MS data with JAVA source code [DOI]
• CPM MatLab toolbox (J Listgarten) - for LC-MS, proteomics, metabolomics and time series data + source code.
• GASP (genedrift.org) - for GC-MS alignment
• AnalyzerPro (SpectralWorks) - for alignment of GC-MS data
• meta-b (Vladimir Likic) - for alignment of LC-MS data with python source code (go SVN)
• spectconnect (MIT) - for alignment of GC-MS data using AMDIS for deconvolution
• ChenomX Profiler (Chenomx) - for binning and alignment of NMR signals (+ DB search)
• KnowItAll Metabolomics Editions (BioRad) - with IntelliBucket bucketing and binning of NMR data (+ DB search)
• MS-Xelerator (MSMETRIX) - Advanced Algorithms for LC/MS Data Processing (Marco Ruijken)
• OBI-Warp (U Texas) - Ordered Bijective Interpolated Warping for LC-MS data [PDF]
![Page 90: In Silico Analysis to Metabolomics](https://reader034.vdocuments.site/reader034/viewer/2022051322/546a46efb4af9fb30d8b4731/html5/thumbnails/90.jpg)
THANK YOU FOR YOUR PATIENCE